MARKET

OFIX

OFIX

Orthofix Medical
NASDAQ

Real-time Quotes | Nasdaq Last Sale

45.74
-0.93
-1.99%
Closed 16:00 03/02 EST
OPEN
46.66
PREV CLOSE
46.67
HIGH
46.95
LOW
45.74
VOLUME
62.31K
TURNOVER
--
52 WEEK HIGH
48.50
52 WEEK LOW
22.11
MARKET CAP
892.48M
P/E (TTM)
37.38
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Spinal Surgery Devices Market Size- Detailed Analysis of Current Industry Figures with Forecasts Growth By 2025
Mar 02, 2021 (Market Insight Reports) -- Selbyville, Delaware The research report titled 'Spinal Surgery Devices Market: Global Market Analysis, Dynamics,...
Market Insight Reports · 1d ago
Medical Implants Market By Application Analysis, Regional Outlook, Competitive Strategies And Forecast 2020 - 2027 by ARC
pune, India, Tue, 02 Mar 2021 00:39:35 / Comserve Inc. / -- Acumen Research and Consulting has announced the addition of the "Global Medical Implants Market:...
Comserve · 1d ago
Spinal Fusion Devices Market Size Worth USD 8.90 Billion by 2027 | The Advancements in Surgical Technology and Rising Demand for Minimally Invasive Spine Surgeries are Significant Factors Influencing Industry Growth, says Emergen Research
The global Spinal Fusion Devices Market will be worth USD 8.90 Billion by 2027, according to a current analysis by Emergen Research. The growth of this market can be attributed to the increasing advancements in surgical technology. The improvements in surg...
GlobeNewswire · 1d ago
Orthofix's (OFIX) Q4 Earnings Top Estimates, Margin Declines
Zacks.com · 1d ago
Prenatal Testing Market Top Manufacturers, Size, Business Scenario, Share, Growth, Insights, Industry Analysis, Trends and Forecasts Report 2027
Mar 01, 2021 (Market Insight Reports) -- The global Prenatal Testing Market is forecasted to be worth USD 8.08 Billion by 2027, according to a current...
Market Insight Reports · 2d ago
Spinal Fusion Devices Market Top Players, Size, Business Scenario, Share, Growth, Insights, Industry Analysis, Trends and Forecasts Report 2027
Market Insight Reports · 2d ago
DJ Orthofix Medical Inc. CEO Jon Serbousek on Q4 2020 Results -- Earnings Call Transcript >OFIX
Dow Jones · 4d ago
BTIG Maintains a Hold Rating on Orthofix (OFIX)
BTIG analyst Ryan Zimmerman maintained a Hold rating on Orthofix (OFIX) today. The company's shares closed last Friday at $47.53, close to its 52-week
SmarterAnalyst · 4d ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of OFIX. Analyze the recent business situations of Orthofix Medical through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average OFIX stock price target is 54.00 with a high estimate of 58.00 and a low estimate of 51.00.
EPS
Institutional Holdings
Institutions: 230
Institutional Holdings: 20.63M
% Owned: 105.72%
Shares Outstanding: 19.51M
TypeInstitutionsShares
Increased
39
886.46K
New
26
416.61K
Decreased
64
1.20M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.55%
Healthcare Equipment & Supplies
-0.56%
Key Executives
Chairman/Director/Independent Director
Ronald Matricaria
President/Chief Executive Officer/Director
Jon Serbousek
Chief Financial Officer
Doug Rice
Chief Financial Officer
Rice Doug
Chief Financial Officer
Douglas Rice
Corporate Executive
Paul Gonsalves
Corporate Executive
Kevin Kenny
Chief Administrative Officer
Kimberley Elting
Independent Director
Jason Hannon
Independent Director
James Hinrichs
Independent Director
Alexis Lukianov
Independent Director
Lilly Marks
Independent Director
Michael Paolucci
Independent Director
Maria Sainz
Independent Director
John Sicard
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
  • Financials
  • Insiders
More
About OFIX
Orthofix Medical Inc., formerly Orthofix International N.V., is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim. The Biologics products include AlloQuent Structural Allografts, Trinity ELITE, Trinity Evolution and VersaShield. The Extremity Fixation products include Fixator, Eight-Plate Guided Growth System and Contours VPS Volar Plating System III. The Spine Fixation products include Hallmark Anterior Cervical Plate System, Ascent LE Posterior Occipital Cervico-Thoracic (POCT) System, Firebird Deformity Correction System, Phoenix Minimally Invasive Spinal Fixation System, LONESTAR Cervical Stand Alone (CSA), SKYHAWK Lateral Interbody Fusion System & Lateral Plate System and CENTURION POCT System.

Webull offers kinds of Orthofix Medical Inc stock information, including NASDAQ:OFIX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OFIX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading OFIX stock methods without spending real money on the virtual paper trading platform.